tiprankstipranks
Advertisement
Advertisement

AU:NX1 Stock Latest News

Nexalis Corrects Directors’ Report as Half-Year Loss Widens on R&D Spend
Company AnnouncementsNexalis Corrects Directors’ Report as Half-Year Loss Widens on R&D Spend
4d ago
NX1
Nexalis Therapeutics Posts Wider Half-Year Loss and Negative Asset Backing
PremiumCompany Announcements
Nexalis Therapeutics Posts Wider Half-Year Loss and Negative Asset Backing
5d ago
NX1
Nexalis Therapeutics Updates Director Sean Williams’ Equity Holdings
PremiumCompany Announcements
Nexalis Therapeutics Updates Director Sean Williams’ Equity Holdings
2M ago
NX1
Nexalis Therapeutics Director Options Lapse Without Share Changes
PremiumCompany Announcements
Nexalis Therapeutics Director Options Lapse Without Share Changes
2M ago
NX1
Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure
PremiumCompany Announcements
Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure
2M ago
NX1
Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights
PremiumCompany AnnouncementsNexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights
2M ago
NX1
Nexalis pays directors in contingent share rights to preserve cash for trials
Premium
Company Announcements
Nexalis pays directors in contingent share rights to preserve cash for trials
2M ago
NX1
Nexalis Faces Funding Uncertainty as IRX-616a Trial Delivers Strong Safety Data
Premium
Company Announcements
Nexalis Faces Funding Uncertainty as IRX-616a Trial Delivers Strong Safety Data
2M ago
NX1
Nexalis reshapes board as CEO steps in as interim director
PremiumCompany Announcements
Nexalis reshapes board as CEO steps in as interim director
2M ago
NX1
Nexalis Trading Reinstated on ASX After Debt Facility Update
PremiumCompany Announcements
Nexalis Trading Reinstated on ASX After Debt Facility Update
3M ago
NX1
Nexalis Secures New $53m Clinical Funding Facility After Lender Exit
PremiumCompany Announcements
Nexalis Secures New $53m Clinical Funding Facility After Lender Exit
3M ago
NX1
Nexalis Therapeutics Seeks Voluntary Suspension Pending Debt Funding Update
PremiumCompany Announcements
Nexalis Therapeutics Seeks Voluntary Suspension Pending Debt Funding Update
3M ago
NX1
Nexalis Therapeutics Requests Trading Halt Ahead of Debt Funding Update
PremiumCompany AnnouncementsNexalis Therapeutics Requests Trading Halt Ahead of Debt Funding Update
4M ago
NX1
Nexalis Therapeutics reshapes board as director steps down
Premium
Company Announcements
Nexalis Therapeutics reshapes board as director steps down
4M ago
NX1
Nexalis Therapeutics Sets Virtual AGM to Vote on Board, Pay and Capital Mandates
Premium
Company Announcements
Nexalis Therapeutics Sets Virtual AGM to Vote on Board, Pay and Capital Mandates
4M ago
NX1
Nexalis Therapeutics Sets Online-Only 2026 AGM and Moves to Digital Meeting Materials
PremiumCompany Announcements
Nexalis Therapeutics Sets Online-Only 2026 AGM and Moves to Digital Meeting Materials
4M ago
NX1
Nexalis calls virtual AGM with pay vote, potential board spill
PremiumCompany Announcements
Nexalis calls virtual AGM with pay vote, potential board spill
4M ago
NX1
Nexalis Boosts Cash Reserves Despite R&D-Driven Outflows
PremiumCompany Announcements
Nexalis Boosts Cash Reserves Despite R&D-Driven Outflows
4M ago
NX1
Nexalis shifts to active trial execution as rebrand caps pipeline expansion
PremiumCompany Announcements
Nexalis shifts to active trial execution as rebrand caps pipeline expansion
4M ago
NX1
Nexalis Advances Inhaled CBD Anxiety Drug to Final Phase 1 Cohort
PremiumCompany AnnouncementsNexalis Advances Inhaled CBD Anxiety Drug to Final Phase 1 Cohort
4M ago
NX1
Nexalis Screens First Patient in Phase 2 IRX-211 Trial for Breakthrough Cancer Pain
Premium
Company Announcements
Nexalis Screens First Patient in Phase 2 IRX-211 Trial for Breakthrough Cancer Pain
5M ago
NX1
Nexalis Advances Phase 1 Trial of Inhaled CBD Therapy for Panic Disorder
Premium
Company Announcements
Nexalis Advances Phase 1 Trial of Inhaled CBD Therapy for Panic Disorder
5M ago
NX1

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >